17 September, 2017
The funds in our partner's database now hold: 21.98 million shares, up from 18.14 million shares in 2016Q3.
The stock decreased 0.76% or $0.18 during the last trading session, reaching $23.61. 172,970 shares of the company's stock traded hands. Flexion Therapeutics Inc (NASDAQ:FLXN) has risen 82.02% since September 14, 2016 and is uptrending. Equities research analysts anticipate that Flexion Therapeutics will post ($3.70) EPS for the current fiscal year. Therefore 100% are positive. Finally, Janney Montgomery Scott reaffirmed a "buy" rating and set a $35.00 target price (up from $30.00) on shares of Flexion Therapeutics in a research note on Wednesday, July 12th. Needham maintained Flexion Therapeutics Inc (NASDAQ:FLXN) rating on Wednesday, September 9. The firm earned "Buy" rating on Monday, June 12 by Cantor Fitzgerald. Lake Street initiated Flexion Therapeutics Inc (NASDAQ:FLXN) rating on Thursday, July 21. Needham & Company LLC reiterated a buy rating and set a $34.00 price objective on shares of Flexion Therapeutics in a research note on Monday, May 15th. Cantor Fitzgerald initiated the shares of FLXN in report on Wednesday, November 4 with "Buy" rating. Finally, Royal Bank Of Canada reissued a buy rating and set a $44.00 target price on shares of Flexion Therapeutics in a research report on Friday, July 7th.
Since January 1, 0001, it had 3 buys, and 2 sales for $360 activity. About 62,836 shares traded. On Friday, June 16 the insider Stejbach Mark bought $26,888. The insider DRISCOLL FREDERICK W sold 3,000 shares worth $69,000. The stock presently has a consensus rating of "Buy" and an average target price of $31.50.
Investors sentiment increased to 1.74 in Q4 2016. Zero analysts have made estimates for Flexion Therapeutics' earnings, with estimates ranging from ($1.02) to ($0.90). It improved, as 8 investors sold FLXN shares while 16 reduced holdings. Sold All: 8 Reduced: 16 Increased: 42 New Position: 19. Dupont Cap Mngmt Corp reported 19,491 shares stake. The stock of Flexion Therapeutics Inc (NASDAQ:FLXN) earned "Buy" rating by BMO Capital Markets on Monday, June 26. Barclays Plc invested in 0% or 60,371 shares. Kingdon Capital Management L.L.C. increased its stake in shares of Flexion Therapeutics by 29.2% in the fourth quarter. "(FLXN) Position Boosted by Schroder Investment Management Group" was originally reported by StockNewsTimes and is owned by of StockNewsTimes. Highbridge Cap Management Limited reported 38,996 shares or 0.01% of all its holdings. Sabby Mngmt Llc invested in 0.01% or 10,914 shares. With an institutional ownership near 49.2%, it carries an earnings per share ratio of -1.92.
ValuEngine upgraded shares of Flexion Therapeutics, Inc. Axiom International Investors Llc De, a Connecticut-based fund reported 1.39 million shares. Zacks Investment Research cut shares of Flexion Therapeutics from a hold rating to a sell rating in a research report on Tuesday, May 9th. Alps Advisors holds 29,913 shares. Sei accumulated 500 shares. Jpmorgan Chase & reported 0% stake.
A number of equities research analysts have commented on FLXN shares.
About 236,476 shares traded. Flexion Therapeutics Inc (NASDAQ:FLXN) has risen 82.02% since September 14, 2016 and is uptrending. It has outperformed by 65.32% the S&P500.The move comes after 6 months positive chart setup for the $778.00M company.
Flexion Therapeutics, Inc.is a United States specialty pharmaceutical company. The company has market cap of $769.56 million. The Company is focused on the development and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. The Company's lead product candidate, Zilretta, is a late-stage, injectable, extended-release, intra-articular (IA) investigational steroid.
Fiduciary Management Inc increased Kennedy (NYSE:KW) stake by 444,490 shares to 1.94 million valued at $39.68 million in 2016Q4. The company's stock had a trading volume of 732,733 shares. Its down 0.05, from 0.94 in 2016Q3. Eam Ltd Liability Corp reported 36,882 shares. Axa holds 0.1% or 239,850 shares. 3,128 are held by Blackrock Group Incorporated Ltd. Benjamin F Edwards And Commerce Inc stated it has 37 shares or 0% of all its holdings. Sg Americas Securities Ltd Llc accumulated 11,874 shares.
Denali Advisors Llc holds 2.9% of its portfolio in Southern Copper Corp for 523,103 shares. Moreover, Dock Street Asset Management has 0.14% invested in Omnicom Group Inc.
Compugen Ltd.is a therapeutic discovery company. Guggenheim Capital Limited accumulated 69,759 shares. The company's institutional ownership is monitored at 0 percent. Keybank Natl Association Oh has 10,357 shares for 0% of their portfolio.
Analysts await Omnicom Group Inc.